{"id":"placebo-mr-prednisone","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5483039","moleculeType":null,"molecularWeight":"393.02"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo-MR Prednisone is a modified-release formulation used as a control arm in clinical trials. As a placebo, it contains no active pharmaceutical ingredient and produces therapeutic effects only through the placebo response. It is used to establish efficacy of the actual prednisone formulation being tested.","oneSentence":"This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:00.893Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trials of modified-release prednisone formulations"}]},"trialDetails":[{"nctId":"NCT00650078","phase":"PHASE3","title":"Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-03","conditions":"Rheumatoid Arthritis","enrollment":350},{"nctId":"NCT00146640","phase":"PHASE3","title":"Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-08-31","conditions":"Rheumatoid Arthritis","enrollment":288}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo - MR Prednisone","genericName":"Placebo - MR Prednisone","companyName":"Merck KGaA, Darmstadt, Germany","companyId":"merck-kgaa-darmstadt-germany","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action. Used for Control arm in Phase 3 clinical trials of modified-release prednisone formulations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}